Literature DB >> 22652185

The role of saposin C in Gaucher disease.

Rafael J Tamargo1, Arash Velayati, Ehud Goldin, Ellen Sidransky.   

Abstract

Saposin C is one of four homologous proteins n class="Chemical">derived from sequential cleavage of the saposin precursor protein, prosaposin. It is an essential activator for glucocerebrosidase, the enzyme deficient in Gaucher disease. Gaucher disease is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GBA gene that exhibits vast phenotypic heterogeneity, despite its designation as a "simple" Mendelian disorder. The observed phenotypic variability has led to a search for disease modifiers that can alter the Gaucher phenotype. The PSAP gene encoding saposin C is a prime candidate modifier for Gaucher disease. In humans, saposin C deficiency due to mutations in PSAP results in a Gaucher-like phenotype, despite normal in vitro glucocerebrosidase activity. Saposin C deficiency has also been shown to modify phenotype in one mouse model of Gaucher disease. The role of saposin C as an activator required for normal glucocerebrosidase function, and the consequences of saposin C deficiency are described, and are being explored as potential modifying factors in patients with Gaucher disease. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652185      PMCID: PMC3534739          DOI: 10.1016/j.ymgme.2012.04.024

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  94 in total

1.  The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.

Authors:  Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

2.  Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations.

Authors:  Benjamin Liou; Andrzej Kazimierczuk; Min Zhang; C Ronald Scott; Rashmi S Hegde; Gregory A Grabowski
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

Review 3.  Molecular chaperones in protein folding and proteostasis.

Authors:  F Ulrich Hartl; Andreas Bracher; Manajit Hayer-Hartl
Journal:  Nature       Date:  2011-07-20       Impact factor: 49.962

Review 4.  The immunological functions of saposins.

Authors:  Alexandre Darmoise; Patrick Maschmeyer; Florian Winau
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

5.  The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin.

Authors:  Stephane Lefrancois; Jibin Zeng; A Jacob Hassan; Maryssa Canuel; Carlos R Morales
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

6.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

7.  In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease.

Authors:  F Y Choy; M Woo; M Potier
Journal:  Biochim Biophys Acta       Date:  1986-03-07

8.  Identification of prosaposin as a neurotrophic factor.

Authors:  J S O'Brien; G S Carson; H C Seo; M Hiraiwa; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

Review 10.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

View more
  39 in total

1.  Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.

Authors:  Navin Rauniyar; Kanagaraj Subramanian; Mathieu Lavallée-Adam; Salvador Martínez-Bartolomé; William E Balch; John R Yates
Journal:  Mol Cell Proteomics       Date:  2015-04-14       Impact factor: 5.911

2.  Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.

Authors:  Raquel Romero; Arvind Ramanathan; Tony Yuen; Debsindhu Bhowmik; Mehr Mathew; Lubna Bashir Munshi; Seher Javaid; Madison Bloch; Daria Lizneva; Alina Rahimova; Ayesha Khan; Charit Taneja; Se-Min Kim; Li Sun; Maria I New; Shozeb Haider; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-26       Impact factor: 11.205

Review 3.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

Review 4.  The protective role of prosaposin and its receptors in the nervous system.

Authors:  Rebecca C Meyer; Michelle M Giddens; Brilee M Coleman; Randy A Hall
Journal:  Brain Res       Date:  2014-08-15       Impact factor: 3.252

5.  Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.

Authors:  Marina Siebert; Wendy Westbroek; Yu-Chi Chen; Nima Moaven; Yan Li; Arash Velayati; Maria Luiza Saraiva-Pereira; Scott E Martin; Ellen Sidransky
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.

Authors:  Clarissa Valdez; Daniel Ysselstein; Tiffany J Young; Jianbin Zheng; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 7.  Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.

Authors:  Jun Yup Lee; Oana C Marian; Anthony S Don
Journal:  Neuromolecular Med       Date:  2021-02-07       Impact factor: 3.843

8.  Saposin C protects glucocerebrosidase against α-synuclein inhibition.

Authors:  Thai Leong Yap; James M Gruschus; Arash Velayati; Ellen Sidransky; Jennifer C Lee
Journal:  Biochemistry       Date:  2013-10-01       Impact factor: 3.162

9.  Sequencing of the GBA coactivator, Saposin C, in Parkinson disease.

Authors:  Bouchra Ouled Amar Bencheikh; Etienne Leveille; Jennifer A Ruskey; Dan Spiegelman; Christopher Liong; Edward A Fon; Guy A Rouleau; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2018-07-02       Impact factor: 4.673

Review 10.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.